KR20180124733A - Process for Producing Deoxypodophilotoxin in Quantity - Google Patents

Process for Producing Deoxypodophilotoxin in Quantity Download PDF

Info

Publication number
KR20180124733A
KR20180124733A KR1020180051133A KR20180051133A KR20180124733A KR 20180124733 A KR20180124733 A KR 20180124733A KR 1020180051133 A KR1020180051133 A KR 1020180051133A KR 20180051133 A KR20180051133 A KR 20180051133A KR 20180124733 A KR20180124733 A KR 20180124733A
Authority
KR
South Korea
Prior art keywords
methanol
column
extract
deoxyglycolipotoxin
diaion
Prior art date
Application number
KR1020180051133A
Other languages
Korean (ko)
Other versions
KR102110966B1 (en
Inventor
안순철
김영욱
유선녕
남효원
안현희
최현덕
김광연
박슬기
김상헌
Original Assignee
부산대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 부산대학교 산학협력단 filed Critical 부산대학교 산학협력단
Publication of KR20180124733A publication Critical patent/KR20180124733A/en
Application granted granted Critical
Publication of KR102110966B1 publication Critical patent/KR102110966B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/121Heterocyclic compounds containing oxygen or sulfur as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention relates to a method for extracting high-purity deoxypodophyllotoxin in quantity by using a column and an alcohol solvent from a substance to be extracted containing the deoxypodophyllotoxin. Conventional purification methods require complicated steps and have a disadvantage in that the yield of deoxypodophyllotoxin finally obtained is low. However, the present invention does not have a process of concentrating after alcohol extraction of the prior art, and the separation of the solvent is not required. Therefore, the present invention is suitable for simple and large-scale extraction of the deoxypodophyllotoxin contained in anticancer drugs and the like.

Description

데옥시포도필로톡신의 대량생산 방법{Process for Producing Deoxypodophilotoxin in Quantity}Technical Field [0001] The present invention relates to a process for producing Deoxypodophyllotoxin in Quantity

본 발명은 추출 대상물로부터 데옥시포도필로톡신을 대량으로 추출 및 생산하는 방법에 관한 것이다.The present invention relates to a method for massive extraction and production of deoxyglyptyltoxin from an object to be extracted.

데옥시포도필로톡신(deoxypodophyllotoxin)은 전호를 비롯한 백두옹(할미꽃[Pulsatilla koreana]의 뿌리), 향나무(Juniperus chinensis L.), 나한백(Thujopsis dolabrata), 토밀수(Bridelia tulasneana) 등에서 분리한다. 데옥시포도필로톡신은 자궁경부암 HeLa 세포, 폐암 A549 세포, 대장암 HCT116 세포, 피부암 B16F10 세포 등의 여러 가지 암세포에서 세포주기를 정지하거나, 세포의 증식 단백질의 발현을 조절하여 세포자멸사(apoptosis)를 유발하거나, 암세포의 혈관 생성을 저해하여 항암 작용을 일으킨다. 또한 oriental armyworm 등의 해충에 대한 살충효과 뿐만 아니라 진통, 항염증 효과, UV에 의한 피부색소 침착을 억제하는 미백 효과, herpes simplex virus에 대한 항바이러스 효과 등이 보고되었다. 특히 데옥시포도필로톡신은 항종양 활성이 우수하여 국내 최초의 천연물 항암제 SB 주사의 주성분으로 보고되었다. 이러한 데옥시포도필로톡신의 함암 효과, 살충효과, 미백효과, 항염증효과 등으로 인해 이는 약물, 화장품, 살충제, 가축사료 등에 널리 사용될 수 있다는 장점을 가진다. Deoxypodophyllotoxin (deoxypodophyllotoxin) is a compound of the genus Pulsatilla koreana ], Juniperus chinensis L.), Hanbaek ( Thujopsis dolabrata ), soil smuggling ( Bridelia tulasneana ) or the like. Deoxyplastin toxin inhibits apoptosis by stopping the cell cycle or controlling the expression of proliferating proteins in various cancer cells such as cervical cancer HeLa cells, lung cancer A549 cells, colon cancer HCT116 cells and skin cancer B16F10 cells. Or inhibits angiogenesis of cancer cells, resulting in an anticancer effect. In addition to the insecticidal effects of oriental armyworms, they have been reported to have analgesic, antiinflammatory effect, whitening effect to suppress skin pigmentation caused by UV, and antiviral effect against herpes simplex virus. In particular, deoxyglycolipotoxin has excellent antitumor activity and is reported to be the main ingredient of SB injection of natural anti - cancer drug in Korea. This is advantageous in that it can be widely used for medicines, cosmetics, insecticides, livestock feed, etc. due to the anti-cancer effect, insecticidal effect, whitening effect and anti-inflammatory effect of deoxyglycolipotoxin.

데옥시포도필로톡신은 백두옹, 전호, 측백나무 등으로부터 메탄올 또는 에탄올 추출 후 실리카겔 칼럼 크로마토그래피 등의 복잡한 분리를 통해 정제되고 있나 고순도로 대량으로 분리, 정제된 보고는 없다. Deoxyglyptyltoxin is purified from methanol extract or ethanol extract from Baekguyong, Jeonho, and Hwangbok after complicated separation such as silica gel column chromatography. However, there has been no reports of separation and purification in large quantity in high purity.

이에 본 발명의 목적은 유용한 물질인 데옥시포도필로톡신을 대량 및 고순도로 추출할 수 있으면서도, 간단한 데옥시포도필로톡신의 추출 방법을 제공하는 것이다.Accordingly, an object of the present invention is to provide a method for extracting deoxyglycolipotoxin, which is a useful substance, in a large amount and at a high purity, while extracting a simple deoxyglycolipotoxin.

상기 과제를 해결하기 위하여, 본 발명의 발명자는 간단하면서도 데옥시포도필로톡신을 대량 및 고순도로 추출할 수 있는 추출 방법을 발명하였으며, 본 발명의 과제 해결 수단은 다음과 같다:In order to solve the above problems, the inventor of the present invention has invented an extraction method which can extract a simple but highly deoxyglycolipotoxin in a large amount and a high purity.

1. 추출 대상물을 100% 알코올로 추출하고, 증류수를 더하여 알코올 80%의 추출액을 제조하는 단계;1. extracting the object to be extracted with 100% alcohol and adding distilled water to prepare an extract of 80% alcohol;

상기 추출액을 칼럼에 통과시키는 단계;Passing the extract through a column;

80% 알코올을 칼럼에 통과시켜 흡착되지 않은 물질을 제거하는 단계;Passing 80% alcohol through the column to remove unadsorbed material;

100% 알코올을 칼럼에 통과시켜 흡착되어 있던 데옥시포도필로톡신을 용출하는 단계;를 포함하는 데옥시포도필로톡신의 추출 방법.100% alcohol is passed through a column to elute deoxyglycolipotoxin which has been adsorbed, thereby extracting deoxyglyptyltoxin.

2. 1에 있어서, 상기 알코올은 메탄올 또는 에탄올인 데옥시포도필로톡신의 추출 방법.2. The method according to claim 1, wherein the alcohol is methanol or ethanol.

본 발명의 데옥시포도필로톡신의 대량 추출방법은 기존의 추출방법인 메탄올 또는 에탄올 추출 후 실리카겔 칼럼 크로마토그래피 등의 복잡한 분리를 통해 정제하는 방법과 비교하여 정제 단계가 간단하며, 고순도 및 대량으로 추출이 가능하다. 또한 수용액 상태에서 추출물을 흡착시키지 않기 때문에 소요되는 수지의 양이 적다.The method of massextraction of deoxyglyptyltoxin of the present invention is simple in purification step compared with the conventional purification method through a complicated separation such as methanol or ethanol extraction and silica gel column chromatography, This is possible. In addition, since the extract is not adsorbed in the aqueous solution state, the amount of resin required is small.

도 1은 본 발명의 실시예 1-2에 따라 Diaion HP-20 수지 및 메탄올 용액을 이용하여 전호로부터 대량으로 데옥시포도필로톡신을 추출하는 방법을 간략화한 도이다.
도 2는 본 발명의 실시예 1-2에 따라 추출된 메탄올 추출물, Diaion HP-20 수지 통과액 및 100% 메탄올 용출액과 데옥시포도필로톡신 표준물질의 고성능액체크로마토그래피(HPLC) 그래프를 비교한 것을 나타낸 도이다.
도 3은 본 발명의 실시예 1-2에 따라 Diaion HP-20 수지의 100% 메탄올 용출액에서는 머무름 9분에 나타나는 물질을 1H-NMR으로 분석한 결과를 나타낸 도이다.
도 4는 본 발명의 실시예 1-2에 따라 분리, 정제된 데옥시포도필로톡신의 항암효과를 MTT 실험방법을 통해 확인한 결과를 나타낸 도이다.
도 5는 본 발명의 실시예 2에 따라 Diaion HP-20 수지 및 에탄올 용액을 이용하여 전호로부터 대량으로 데옥시포도필로톡신을 추출하는 방법을 간략화한 도이다.
도 6은 본 발명의 실시예 2에 따라 추출된 에탄올 추출물, Diaion HP-20 수지 통과액 및 100% 에탄올 용출액과 데옥시포도필로톡신 표준물질의 고성능액체크로마토그래피(HPLC) 그래프를 비교한 것을 나타낸 도이다.
도 7은 본 발명의 실시예 2에 따라 Diaion HP-20 수지의 100% 에탄올 용출액에서는 머무름 9분에 나타나는 물질을 1H-NMR으로 분석한 결과를 나타낸 도이다.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a simplified view of a method for extracting deoxypluginous phytotoxin in large quantities from Duanion HP-20 resin and methanol solution according to Example 1-2 of the present invention.
2 is a graph comparing high performance liquid chromatography (HPLC) graphs of the methanol extract, Diaion HP-20 resin passage liquid and 100% methanol eluent and deoxyglycolipotoxin standard material extracted according to Example 1-2 of the present invention Fig.
FIG. 3 is a graph showing the results of 1 H-NMR analysis of a substance appearing at 9 minutes retention in 100% methanol eluate of Diaion HP-20 resin according to Example 1-2 of the present invention.
FIG. 4 is a graph showing the anticancer effect of deoxyplastin toxin isolated and purified according to Example 1-2 of the present invention through MTT assay. FIG.
FIG. 5 is a simplified view of a method of extracting deoxypluginous phytotoxin in a large amount from the Korean Pharmacopoeia using a Diaion HP-20 resin and an ethanol solution according to Example 2 of the present invention.
FIG. 6 shows a comparison of high performance liquid chromatography (HPLC) graphs of the ethanol extract, Diaion HP-20 resin passage liquid and 100% ethanol eluent and deoxyglycolipotoxin standard material extracted according to Example 2 of the present invention .
FIG. 7 is a graph showing the results of 1 H-NMR analysis of a substance appearing at a retention time of 9 minutes in a 100% ethanol eluate of Diaion HP-20 resin according to Example 2 of the present invention. FIG.

본 발명은 추출 대상물의 80% 알코올 추출액을 크로마토그래피 칼럼에 통과시켜 데옥시포도필로톡신을 칼럼에 흡착시키는 단계;The present invention relates to a method for preparing an extract, comprising the steps of: passing an 80% alcohol extract of an object to be extracted through a chromatography column to adsorb deoxyplugin toxin to the column;

80% 알코올을 상기 칼럼에 통과시켜 흡착되지 않은 물질을 용출시키는 단계;Passing 80% alcohol through the column to elute the non-adsorbed material;

100% 알코올을 상기 칼럼에 통과시켜 흡착되어 있던 데옥시포도필로톡신을 용출시키는 단계;를 포함하는 데옥시포도필로톡신의 추출 방법을 제공한다.100% alcohol is passed through the column to elute deoxyglycolipotoxin which has been adsorbed, thereby providing a method for extracting deoxyglycolipotoxin.

추출 대상물의 80% 알코올 추출액을 크로마토그래피 칼럼에 통과시키는 단계에서 데옥시포도필로톡신은 칼럼에 흡착하게 되고, 이를 제외한 다른 성분은 칼럼을 통과하여 분리된다. 그 후 남아있는 흡착되지 않은 물질을 제거하기 위해 80% 알코올을 칼럼에 통과시켜 이를 제거한다. 마지막으로 100% 알코올을 칼럼에 통과시켜 흡착되어 있던 데옥시포도필로톡신을 용출하고, 그 결과 데옥시포도필로톡신이 고순도로 용해되어 있는 알코올 용액을 수득하게 된다.In the step of passing the 80% alcohol extract of the object to be extracted through the chromatography column, the deoxyglycolyticoxin is adsorbed on the column, and the other ingredients are separated through the column. Thereafter, 80% alcohol is passed through the column to remove any remaining unadsorbed material. Finally, 100% alcohol is passed through the column to elute deoxyglycolipotoxin adsorbed. As a result, an alcohol solution in which deoxyglycolipotoxin is dissolved in high purity is obtained.

수득된 알코올 용액에서 알코올을 증발시키거나 분리시켜 데옥시포도필로톡신을 정제할 수 있다.The alcohol can be evaporated or separated in the obtained alcohol solution to purify deoxyglycolipotoxin.

본 발명에 있어서, 상기 알코올은 하나 이상의 -OH기를 갖는 모든 화합물을 지칭하며, 바람직하게는 상기 알코올은 메탄올 또는 에탄올이다.In the present invention, the alcohol refers to all compounds having at least one -OH group, and preferably the alcohol is methanol or ethanol.

본 발명에 있어서, 추출 대상물은 데옥시포도필로톡신을 함유하고 있는 어떠한 것이어도 무방하다. 예컨대, 본 발명의 추출대상물은 전호, 백두옹, 향나무, 측백나무, 나한백 및 토밀수로 이루어진 군에서 선택되는 것일 수 있으나, 이에 한정되지 않는다.In the present invention, the subject to be extracted may be any one containing deoxyglycolipotoxin. For example, the subject to be extracted of the present invention may be selected from the group consisting of Korean pepper, white pepper, juniper, Japanese white pine, Japanese white pine, and Korean soil, but is not limited thereto.

본 발명에 있어서, 칼럼은 80% 알코올보다는 데옥시포도필로톡신과의 인력이 크면서, 100% 알코올보다는 데옥시포도필로톡신과의 인력이 작은 것을 사용하여야 한다. 그 예로는 활성탄, Diaion HP-20 수지 및 Amberlite XAD-20 수지 등이 있으나, 상기 조건을 만족하는 것이라면 활성탄, Diaion HP-20 수지 및 Amberlite XAD-20 수지 이외에도 다른 것을 사용할 수 있다. In the present invention, the columns should have a smaller grafting with deoxyplastin rather than 100% alcohol with greater gravity than deoxyglycolipotoxin, rather than 80% alcohol. Examples thereof include activated carbon, Diaion HP-20 resin, and Amberlite XAD-20 resin. However, if it satisfies the above conditions, it is possible to use other than activated carbon, Diaion HP-20 resin and Amberlite XAD-20 resin.

실시예Example

이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예, 비교예 및 실험예를 제시한다. 그러나 하기의 실시예, 비교예 및 실험예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 실시예, 비교예 및 실험예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred embodiments, comparative examples, and experimental examples are provided to facilitate understanding of the present invention. However, the following examples, comparative examples and experimental examples are provided only for the purpose of easier understanding of the present invention, and the present invention is not limited by the examples, comparative examples and experimental examples.

실시예 1. 메탄올을 이용한 데옥시포도필로톡신의 추출EXAMPLES Example 1. Extraction of deoxyglycolipotoxin with methanol

실시예 1-1. 추출 용매의 선택Example 1-1. Selection of extraction solvent

추출에 사용되는 용매를 선택하기 위해, 열수 추출, 50% 메탄올 추출 및 100% 메탄올 추출을 수행하고 그 결과를 비교하였다. 구체적으로는 전호 10 g을 사용하여 100℃에서 10분간 열수 추출하거나 50% 메탄올과 100% 메탄올을 사용하여 24시간 동안 상온에서 메탄올로 추출한 후, 감압원심증발기(SpeedVac)를 이용하여 추출물의 고형분 함량을 측정하였으며 부탄올(butanol)로 용매추출한 추출물에 포함되어 있는 데옥시포도필로톡신의 함량은 고성능액체크로마토그래피(HPLC)를 이용하여 측정하였다. 열수 추출 방법과 메탄올의 함량에 따른 메탄올 추출 방법을 통해 전호로부터 추출된 추출물의 고형분 함량이 달라지고 그 속에 포함되어 있는 데옥시포도필로톡신의 함량에도 차이가 있었으며, 그 결과를 하기 표 1로 정리하였다.To select the solvent used for extraction, hot water extraction, 50% methanol extraction and 100% methanol extraction were performed and the results were compared. Specifically, 10 g of the extract was subjected to hot water extraction at 100 ° C. for 10 minutes or methanol extraction at room temperature for 24 hours using 50% methanol and 100% methanol, and then the solid content of the extract was measured using a reduced pressure centrifugal evaporator (SpeedVac) And the content of deoxyglycolipotoxin contained in the solvent extracted with butanol was measured by high performance liquid chromatography (HPLC). The content of deoxyglycolipotoxin contained in the extracts was different from that of the extracts obtained by the method of hot water extraction and methanol extraction according to the content of methanol. The results are summarized in the following Table 1 Respectively.

추출 방법Extraction method 추출물의
고형분 함량
Extract
Solids content
부탄올 추출물의
고형분 함량
Of butanol extract
Solids content
부탄올 추출물의
데옥시포도필로톡신 함량
Of butanol extract
Deoxyplastin toxin content
수율 (%)
(DPT/고형분)
Yield (%)
(DPT / solid content)
열수 추출Hot water extraction 2.95 g2.95 g 0.12 g0.12 g 15.95 mg15.95 mg 0.540.54 50% 메탄올 추출50% methanol extract 2.67 g2.67 g 0.14 g0.14 g 67.20 mg67.20 mg 2.522.52 100% 메탄올 추출100% methanol extract 1.57 g1.57 g 0.15 g0.15 g 66.79 mg66.79 mg 4.254.25

즉, 열수 추출 방법으로 추출되는 고형분의 함량은 가장 많았지만 데옥시포도필로톡신의 함량이 가장 낮았다. 50% 메탄올 추출 방법은 추출되는 고형분의 함량이 많을 뿐만 아니라 데옥시포도필로톡신의 함량도 높았다. 100% 메탄올 추출 방법은 추출되는 고형분의 함량은 적었지만, 추출물 속에 포함되어 있는 데옥시포도필로톡신의 함량은 50% 메탄올 추출 방법과 비슷한 수준을 나타내어 사용한 세 가지 추출방법 중 가장 높은 4.25%의 수율(데옥시포도필로톡신의 함량/고형분의 함량)을 나타냈다. 이러한 결과를 바탕으로 가장 효율적으로 데옥시포도필로톡신을 추출하기 위한 용매로 100% 메탄올을 선택하였다.That is, the content of the solid extracted by the hot water extraction method was the highest, but the content of deoxyglycolipotoxin was the lowest. In the 50% methanol extraction method, not only the content of the extracted solid was high but also the content of deoxyglycolipotoxin was high. In the 100% methanol extraction method, the content of the extracted solid matter was small, but the content of deoxyglycolyticoxine contained in the extract was similar to that of the 50% methanol extraction method. Thus, the yield of 4.25% (Content of deoxyplugin toxin / content of solid content). Based on these results, 100% methanol was selected as the most effective solvent for extracting deoxyplastin toxin.

실시예 1-2. 전호로부터 데옥시포도필로톡신의 대량 추출 Examples 1-2. Large-scale extraction of deoxyglyptyltoxin from the former

건조 전호 10 ㎏을 대용량 믹서기로 잘게 분쇄한 후, 분쇄한 전호에 100% 메탄올 45ℓ를 넣어 2일 동안 상온에서 추출하였다. 1차 추출물을 회수한 후 100% 메탄올 45ℓ를 다시 넣어 동일한 조건에서 2차 및 3차 추출을 실시하였다. 3차 추출까지 완료한 후 100% 메탄올 추출액의 침전물을 여과지로 제거하고 증류수를 가하여 메탄올의 농도가 80%가 되도록 맞추었다. 미리 80% 메탄올에 평형화 시킨 약 4.5ℓ 부피의 Diaion HP-20 칼럼에 최종 농도가 80% 메탄올로 희석한 전호의 메탄올 추출물을 통과시켜 데옥시포도필로톡신을 포함한 지용성 물질을 흡착시켰다. 추출액을 모두 통과시킨 후, 80% 메탄올 20ℓ를 사용하여 Diaion HP-20에 흡착되지 않은 물질을 씻어냈다. 그 후 100% 메탄올을 사용하여 Diaion HP-20에 흡착되어 있던 데옥시포도필로톡신을 용출시켰다. 데옥시포도필로톡신이 포함된 100% 메탄올 용출액을 진공회전농축기(evaporator)로 메탄올 제거하고 고성능액체크로마토그래피로 분석하여 순도 80%의 데옥시포도필로톡신 분획 29.7 g을 얻었다. 본 실시예의 추출 과정을 도 1로 간략화하여 나타내었다. 10 kg of the dry bulb was crushed finely with a large-capacity mixer, and 45 liters of 100% methanol was added to the milled mixture and extracted at room temperature for 2 days. After the first extract was recovered, 45 liters of 100% methanol was added again, and the second and third extraction were carried out under the same conditions. After completion of the third extraction, the precipitate of the 100% methanol extract was removed with a filter paper, and distilled water was added thereto to adjust the concentration of methanol to 80%. Lipophilic substances including deoxyglycolyticoxin were adsorbed on a Diaion HP-20 column, which had been equilibrated with 80% methanol in advance, through a methanol extract of the former, which had been diluted with 80% methanol to a final volume of about 4.5 liters. After all of the extract was passed through, 20 l of 80% methanol was used to rinse the unadsorbed material on the Diaion HP-20. Then, 100% methanol was used to elute deoxyglycolyticoxin adsorbed on Diaion HP-20. 100% methanol eluate containing deoxyplastin toxin was removed by methanol with a vacuum rotary evaporator and analyzed by high performance liquid chromatography to obtain 29.7 g of deoxyglycolyticoxin fraction having a purity of 80%. The extraction process of this embodiment is shown in FIG. 1 in a simplified manner.

비교예 1. 기존의 추출방법인 메탄올 추출 후 실리카겔 칼럼 크로마토그래피 등의 복잡한 분리를 통해 정제한 결과COMPARATIVE EXAMPLE 1 After the conventional extraction method, methanol extraction, purification was carried out through complicated separation such as silica gel column chromatography

먼저 전호 500 g을 메탄올로 추출한 후 회전증발기로 메탄올을 증발시키고 고형성분만 남게 하였다. 남은 고형 성분에 물과 에틸아세테이트(ethylacetate)를 동량으로 가한 후 에틸아세테이트 층만 취하였다. 에틸아세테이트 층에 실리카겔을 넣고 회전증발기로 에틸아세테이트를 제거하여 고형성분을 실리카겔에 흡착 시킨 후, 미리 충진된 실리카겔 칼럼에 가하여 헥세인(hexane)과 에틸아세테이트를 3대 1로 혼합한 용액을 전개용매로 용출하여 데옥시포도필로톡신이 포함된 분획을 얻었다. 용리된 데옥시포도필로톡신을 포함하는 분획을 앞과 같은 방법으로 C18-역상 실리카겔에 흡착하고 충진된 칼럼을 이용하여 60% 메탄올을 전개용매로 하여 데옥시포도필로톡신을 용리시켰다. 데옥시포도필로톡신을 포함하는 분획을 회전증발기로 농축시키고 Sepadex LH-20 칼럼에 가하고 100% 메탄올을 전개용매로 하여 용리하였다. 용리된 데옥시포도필로톡신을 포함하는 분획을 고성능액체크로마토그래피(HPLC, high performance liquid chromatography)를 이용하여 C18 칼럼, 60% 메탄올을 전개용매 조건으로 분리 및 분획하여 순수한 데옥시포도필로톡신 50 mg을 얻었다.First, 500 g of the extract was extracted with methanol, and the methanol was evaporated with a rotary evaporator to leave only the solid component. The remaining solid was added with water and ethyl acetate (ethylacetate) in an equal volume and only the ethyl acetate layer was removed. A silica gel was added to the ethyl acetate layer, and ethyl acetate was removed by a rotary evaporator to adsorb the solid component on silica gel. The solid component was added to a silica gel column previously packed, and hexane and ethyl acetate were mixed in a ratio of 3: 1, To obtain a fraction containing deoxyplugin toxin. The fraction containing eluted deoxyplateletoxin was adsorbed onto C 18 -reversed phase silica gel in the same manner as described above, and deoxyglycolipotoxin was eluted with 60% methanol as a developing solvent using a packed column. The fractions containing deoxyplastin toxin were concentrated on a rotary evaporator, added to a Sepadex LH-20 column and eluted with 100% methanol as eluent. The fractions containing eluted deoxyplastin toxin were separated and fractionated on a C 18 column and 60% methanol using high performance liquid chromatography (HPLC) under developing solvent conditions to obtain pure deoxyglycolipotoxin 50 mg.

이를 본원발명의 실시예 1-2과 비교한 결과를 하기 표 2로 정리하였다.The results are shown in Table 2 below.

정제법Refining method 초기 전호의 양Amount of initial volume 추출물의
고형분 함량
Extract
Solids content
최종 추출물의
고형분 함량
Of the final extract
Solids content
최종 추출물의
DPT 함량
Of the final extract
DPT content
순도 (%)
(DPT/고형분)
Purity (%)
(DPT / solid content)
비교예 1Comparative Example 1 500 g500 g 79 g79 g 52 mg52 mg 50 mg50 mg >95 순수분리)> 95 pure separation) 실시예 1-2Examples 1-2 10 kg10 kg 1,065g1,065g 37 g37 g 29.7 g29.7 g 8080

최종 정제 후 데옥시포도필로톡신의 순도의 경우 비교예의 정제방법은 95% 이상의 순수분리를 보여주었으며 본 발명에 따른 실시예의 정제방법은 대량의 전호를 간단한 방법으로 정제하였음에도 불구하고 80%의 높은 순도를 나타내었다. 특히 전호추출물로부터의 수율(최종 추출물의 데옥시포도필로톡신 함량/추출물의 고형분 함량)을 고려하면 비교예의 정제법은 0.06%이었으나 본 발명에 따른 실시예의 정제법에 의해서는 2.8%의 고효율로 데옥시포도필로톡신을 정제할 수 있었다.In the case of the purity of deoxypluginous phytotoxin after the final purification, the purification method of the comparative example showed a pure water separation of not less than 95%, and the purification method of the example according to the present invention showed a high purity of 80% Respectively. In particular, considering the yield from the extract (total deoxypluginous phytotoxin content of the final extract / solid content of the extract), the purification method of the comparative example was 0.06%, but according to the purification method of the example according to the present invention, the efficiency of 2.8% It was possible to purify oxytocin phytotoxin.

실험예 1-1. 실시예 1-2의 방법으로 추출 및 정제한 데옥시포도필로톡신의 HPLC 분석Experimental Example 1-1. HPLC analysis of deoxyglycolipotoxin extracted and purified by the method of Example 1-2

Diaion HP-20 칼럼에 흘려주어 통과한 분획과 Diaion HP-20에 흡착되어 100% 메탄올에 용출된 분획을 표준물질 데옥시포도필로톡신과 비교하여 고성능액체크로마토그래피 분석을 실시하였다. 데옥시포도필로톡신의 표준물질, 전호의 메탄올 추출물, Diaion HP-20 수지 통과액, Diaion HP-20 수지에서 100% 메탄올 용출액 등의 분석 조건은 다음과 같다. 영인과학의 YL9100 HPLC에서 칼럼은 Waters Spherisorb ODS2 (Ø 4.6x150 mm, 5 μm)를 사용하였으며 전개용매로는 60% 메탄올을 유속 0.8 mL/min 유지하여 용출하여 UV 240 nm에서 검출하였다. 분석 결과는 도 2로 도시하였다. 전호 메탄올 추출물에서는 머무름 시간 9분에서 데옥시포도필로톡신의 피크가 관찰되었으나 Diaion HP-20 수지 통과액에서는 데옥시포도필로톡신이 관찰되지 않았다. 한편 Diaion HP-20 수지의 100% 메탄올 용출액에서는 머무름 9분에서 데옥시포도필로톡신의 피크가 관찰되어 Diaion HP-20 수지에 의해서 데옥시포도필로톡신이 순수하게 분리되는 것을 알 수 있었다. 고성능액체크로마토그래피 분석에서 머무름 9분에 나타나는 물질을 동정하기 위하여 양성자 핵자기공명 분광기(1H-NMR)로 분석하였으며, 그 결과를 도 3으로 도시하였다. 상기 물질의 스펙트럼은 표준물질 데옥시포도필로톡신의 스펙트럼과 동일하여 Diaion HP-20 수지의 100% 메탄올 용출액의 주성분이 데옥시포도필로톡신임을 확인 할 수 있었다. The fraction passed through the Diaion HP-20 column and the fraction eluted in 100% methanol adsorbed on Diaion HP-20 were compared with the standard deoxyglycolyticoxin and subjected to high performance liquid chromatography analysis. The analytical conditions of the deoxysuggestinoctoxin standard material, the methanol extract of the former, the Diaion HP-20 resin passage liquid, and the 100% methanol eluate in the Diaion HP-20 resin are as follows. YL9100 HPLC column from Yeungin Scientific was using Waters Spherisorb ODS2 (Ø 4.6x150 mm, 5 μm) and 60% methanol was eluted with a flow rate of 0.8 mL / min and detected at UV 240 nm. The results of the analysis are shown in Fig. In the methanol extract of prodrug, a peak of deoxyglycolyticoxine was observed at a retention time of 9 minutes, but deoxyglycolyticoxine was not observed in the Diaion HP-20 resin solution. On the other hand, in the 100% methanol eluate of Diaion HP-20 resin, a peak of deoxyglycolyticoxine was observed at a retention time of 9 minutes, and it was found that deoxyglycolyticoxine was purely separated by Diaion HP-20 resin. The high-performance liquid chromatography analysis was carried out by proton nuclear magnetic resonance spectroscopy ( 1 H-NMR) in order to identify the substance appearing at 9 minutes retention, and the results are shown in FIG. The spectrum of this material was the same as that of the standard deoxyplateletoxin, so that it was confirmed that the main component of the 100% methanol eluate of Diaion HP-20 resin is deoxyglycolyticoxin.

실험예 1-2. 실시예 1-2의 방법으로 추출 및 정제한 데옥시포도필로톡신의 항암효과 실험Experimental Example 1-2. Anticancer effect test of deoxyglycolipotoxin extracted and purified by the method of Example 1-2

데옥시포도필로톡신은 전립선암세포, 유방암세포, 폐암세포를 포함한 다양한 암세포에서 항암효과를 나타내는 것으로 알려졌다. 본 발명에 따른 정제방법으로 전호로부터 분리한 데옥시포도필로톡신이 이러한 효능을 가지는 지를 MTT 실험방법을 통하여 확인하였다. 인간전립선암 세포주인 PC-3 세포를 1×104 cells/well의 농도로 세포 배양용 48-well plate에 분주하여 24시간 동안 안정화시킨 후 2.75, 7.5, 15, 30 ng/ml 농도의 데옥시포도필로톡신을 처리하였다. 24시간 반응 후, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 시약을 0.5 mg/ml 농도로 각각 250 μl 첨가하여 37℃에서 2시간 동안 반응시켰다. 반응이 끝난 후, 상등액을 제거하고 생성된 formazan에 dimethylsulfoxide (DMSO) 250 μl를 각각 분주하여 96-well plate로 100 μl씩 옮긴 후, VERSAMAX microplate reader를 이용하여 570 nm에서 흡광도를 측정하여 세포의 생존 능력(cell vaibility)을 측정하였다. 그 결과는 도 4로 도시하였으며, 기존에 알려진대로 본 발명에 따른 Diaion HP-20 수지를 이용한 정제방법을 사용하여 전호로부터 분리한 데옥시포도필로톡신이 인간전립선암 세포주에서 항암효과를 나타내는 것을 확인하였다. Deoxyglobulatoxin is known to have anticancer effects in various cancer cells including prostate cancer cells, breast cancer cells and lung cancer cells. In the purification method according to the present invention, the effect of deoxyglycolipotoxin isolated from the prior art was confirmed by MTT assay. PC-3 cells, a human prostate cancer cell line, were seeded in a 48-well plate for cell culture at a concentration of 1 × 10 4 cells / well and stabilized for 24 hours. Then, deoxyribonucleotides at concentrations of 2.75, 7.5, 15 and 30 ng / The grape pylotoxin was treated. After 24 hours of reaction, 250 μl of 0.5 μg / ml of 3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide (MTT) reagent was added and reacted at 37 ° C for 2 hours. After the reaction was over, and after removing the supernatant was dispensed to each of a dimethylsulfoxide (DMSO) to 250 μl The resulting formazan moved by 100 μl in 96-well plate, VERSA MAX Cell viability was measured by measuring the absorbance at 570 nm using a microplate reader. The results are shown in FIG. 4. As is known in the art, it was confirmed that deoxyplastin toxin isolated from Korean Prolactin using the purification method using Diaion HP-20 resin according to the present invention had an anticancer effect in a human prostate cancer cell line Respectively.

실시예 2. 에탄올을 이용한 전호로부터 데옥시포도필로톡신의 대량 추출 방법 Example 2 Mass Extraction of Deoxyglypylotoxin from Ethanol-Use

메탄올 대신 에탄올을 추출 용매로 사용하여 다음과 같은 방법으로 추출 절차를 수행하였다. 건조 전호 30 ㎏을 대용량 믹서기로 잘게 분쇄한 후, 분쇄한 전호에 100% 에탄올 80ℓ를 넣어 2일 동안 상온에서 추출하였다. 1차 추출물을 회수한 후 100% 에탄올 80ℓ를 다시 넣어 동일한 조건에서 2차 및 3차 추출을 실시하였다. 3차 추출까지 완료한 후 100% 에탄올 추출액의 침전물을 여과지로 제거하고 증류수를 가하여 에탄올의 농도가 80%가 되도록 맞추었다. 미리 80% 에탄올에 평형화 시킨 약 6.6ℓ 부피의 Diaion HP-20 칼럼에 최종 농도가 80% 에탄올로 희석한 전호의 에탄올 추출물을 통과시켜 데옥시포도필로톡신을 포함한 지용성 물질을 흡착시켰다. 추출액을 모두 통과시킨 후, 80% 에탄올 30ℓ를 사용하여 Diaion HP-20에 흡착되지 않은 물질을 씻어냈다. 그 후 100% 에탄올을 사용하여 Diaion HP-20에 흡착되어 있던 데옥시포도필로톡신을 용출시켰다. 데옥시포도필로톡신이 포함된 100% 에탄올 용출액을 진공회전농축기(evaporator)로 에탄올을 제거하고 고성능액체크로마토그래피로 분석하여 순도 80%의 데옥시포도필로톡신 분획 100.6 g을 얻었다. 본 실시예의 추출 과정을 도 5로 간략화하여 나타내었다. The extraction procedure was carried out as follows using ethanol as an extraction solvent instead of methanol. 30 ㎏ of dry bulb was finely pulverized with a large-capacity blender, and 80 ℓ of 100% ethanol was added to the pulverized precursor and extracted at room temperature for 2 days. After the first extract was recovered, 80 liters of 100% ethanol was added again, and the second and third extraction were carried out under the same conditions. After completion of the third extraction, the precipitate of the 100% ethanol extract was removed with a filter paper, and distilled water was added thereto to adjust the concentration of ethanol to 80%. A lipophilic substance including deoxyglycolyticoxin was adsorbed on the Diaion HP-20 column, which had been pre-equilibrated with 80% ethanol in advance, through a Diaion HP-20 column, which had been diluted with 80% ethanol. After all of the extract was passed through, 30 L of 80% ethanol was used to rinse the unadsorbed material on Diaion HP-20. Then, 100% ethanol was used to elute deoxyglycolyticoxin adsorbed on Diaion HP-20. The 100% ethanol eluate containing deoxyplastin toxin was removed by ethanol with a vacuum rotary evaporator and analyzed by high performance liquid chromatography to obtain 100.6 g of a deoxyplastin toxin fraction having a purity of 80%. The extraction process of this embodiment is shown in FIG. 5 in a simplified manner.

비교예 2. 기존의 추출방법인 에탄올 추출 후 실리카겔 칼럼 크로마토그래피 등의 복잡한 분리를 통해 정제한 결과COMPARATIVE EXAMPLE 2 After the ethanol extraction, which is a conventional extraction method, purification through a complicated separation such as silica gel column chromatography

먼저 전호 500 g을 에탄올로 추출한 후 회전증발기로 에탄올을 증발시키고 고형성분만 남게 하였다. 남은 고형 성분에 물과 에틸아세테이트(ethylacetate)를 동량으로 가한 후 에틸아세테이트 층만 취하였다. 에틸아세테이트 층에 실리카겔을 넣고 회전증발기로 에틸아세테이트를 제거하여 고형성분을 실리카겔에 흡착 시킨 후, 미리 충진된 실리카겔 칼럼에 가하여 헥세인(hexane)과 에틸아세테이트를 3대 1로 혼합한 용액을 전개용매로 용출하여 데옥시포도필로톡신이 포함된 분획을 얻었다. 용리된 데옥시포도필로톡신을 포함하는 분획을 앞과 같은 방법으로 C18-역상 실리카겔에 흡착하고 충진된 칼럼을 이용하여 60% 에탄올을 전개용매로 하여 데옥시포도필로톡신을 용리시켰다. 데옥시포도필로톡신을 포함하는 분획을 회전증발기로 농축시키고 Sepadex LH-20 칼럼에 가하고 100% 에탄올을 전개용매로 하여 용리하였다. 용리된 데옥시포도필로톡신을 포함하는 분획을 고성능액체크로마토그래피(HPLC, high performance liquid chromatography)를 이용하여 C18 칼럼, 60% 에탄올을 전개용매 조건으로 분리 및 분획하여 순수한 데옥시포도필로톡신 50 mg을 얻었다.First, 500 g of the extract was extracted with ethanol, and the ethanol was evaporated with a rotary evaporator to leave only the solid component. The remaining solid was added with water and ethyl acetate (ethylacetate) in an equal volume and only the ethyl acetate layer was removed. A silica gel was added to the ethyl acetate layer, and ethyl acetate was removed by a rotary evaporator to adsorb the solid component on silica gel. The solid component was added to a silica gel column previously packed, and hexane and ethyl acetate were mixed in a ratio of 3: 1, To obtain a fraction containing deoxyplugin toxin. The fraction containing eluted deoxyplateletoxin was adsorbed onto C 18 -reversed phase silica gel in the same manner as described above, and deoxyglycolipotoxin was eluted with 60% ethanol as a developing solvent using a packed column. The fraction containing deoxyplastin toxin was concentrated on a rotary evaporator, added to a Sepadex LH-20 column and eluted with 100% ethanol as developing solvent. The fractions containing eluted deoxyplastin toxin were separated and fractionated on a C 18 column and 60% ethanol using developing solvent (HPLC) and high performance liquid chromatography (HPLC) to obtain pure deoxyplastin 50 mg.

이를 본원발명의 실시예 1-2과 비교한 결과를 하기 표 3으로 정리하였다.The results are shown in Table 3 below in comparison with Examples 1-2 of the present invention.

정제법Refining method 초기 전호의 양Amount of initial volume 추출물의
고형분 함량
Extract
Solids content
최종 추출물의
고형분 함량
Of the final extract
Solids content
최종 추출물의
DPT 함량
Of the final extract
DPT content
순도 (%)
(DPT/고형분)
Purity (%)
(DPT / solid content)
비교예 2Comparative Example 2 500 g500 g 79 g79 g 52 mg52 mg 50 mg50 mg >95 순수분리)> 95 pure separation) 실시예 2Example 2 30 kg30 kg 3,197g3,197 g 125.2 g125.2 g 100.6 g100.6 g 8080

최종 정제 후 데옥시포도필로톡신의 순도의 경우 비교예의 정제방법은 95% 이상의 순수분리를 보여주었으며 본 발명에 따른 실시예의 정제방법은 대량의 전호를 간단한 방법으로 정제하였음에도 불구하고 80%의 높은 순도를 나타내었다. 특히 전호추출물로부터의 수율(최종 추출물의 데옥시포도필로톡신 함량/추출물의 고형분 함량)을 고려하면 비교예의 정제법은 0.06%이었으나 본 발명에 따른 실시예의 정제법에 의해서는 3.1%의 고효율로 데옥시포도필로톡신을 정제할 수 있었다.In the case of the purity of deoxypluginous phytotoxin after the final purification, the purification method of the comparative example showed a pure water separation of not less than 95%, and the purification method of the example according to the present invention showed a high purity of 80% Respectively. In particular, considering the yield from the extract (total deoxypluginous phytotoxin content of the final extract / solid content of the extract), the purification method of the comparative example was 0.06%, but according to the purification method of the example according to the present invention, the efficiency was 3.1% It was possible to purify oxytocin phytotoxin.

실험예 2. 실시예 2의 방법으로 추출 및 정제한 데옥시포도필로톡신의 HPLC 분석Experimental Example 2. HPLC analysis of deoxyglycolipotoxin extracted and purified by the method of Example 2

Diaion HP-20 칼럼에 흘려주어 통과한 분획과 Diaion HP-20에 흡착되어 100% 에탄올에 용출된 분획을 표준물질 데옥시포도필로톡신과 비교하여 고성능액체크로마토그래피 분석을 실시하였다. 데옥시포도필로톡신의 표준물질, 전호의 에탄올 추출물, Diaion HP-20 수지 통과액, Diaion HP-20 수지에서 100% 에탄올 용출액 등의 분석 조건은 다음과 같다. 영인과학의 YL9100 HPLC에서 칼럼은 Waters Spherisorb ODS2 (Ø 4.6x150 mm, 5 μm)를 사용하였으며 전개용매로는 60% 에탄올을 유속 0.8 mL/min 유지하여 용출하여 UV 240 nm에서 검출하였다. 분석 결과는 도 6으로 도시하였다. 전호 에탄올 추출물에서는 머무름 시간 9분에서 데옥시포도필로톡신의 피크가 관찰되었으나 Diaion HP-20 수지 통과액에서는 데옥시포도필로톡신이 관찰되지 않았다. 한편 Diaion HP-20 수지의 100% 에탄올 용출액에서는 머무름 9분에서 데옥시포도필로톡신의 피크가 관찰되어 Diaion HP-20 수지에 의해서 데옥시포도필로톡신이 순수하게 분리되는 것을 알 수 있었다. 고성능액체크로마토그래피 분석에서 머무름 9분에 나타나는 물질을 동정하기 위하여 양성자 핵자기공명 분광기(1H-NMR)로 분석하였으며, 그 결과를 도 7으로 도시하였다. 상기 물질의 스펙트럼은 표준물질 데옥시포도필로톡신의 스펙트럼과 동일하여 Diaion HP-20 수지의 100% 에탄올 용출액의 주성분이 데옥시포도필로톡신임을 확인 할 수 있었다. The fraction passed through the Diaion HP-20 column and the fraction eluted with 100% ethanol adsorbed on Diaion HP-20 were compared with the standard deoxyglycolyticoxin and subjected to high performance liquid chromatography analysis. The standard conditions for deoxyplastin toxin, ethanol extract of Jeongho, Diaion HP-20 resin, and Diaion HP-20 resin are as follows. YL9100 HPLC column from Yeungin Scientific was using Waters Spherisorb ODS2 (Ø 4.6x150 mm, 5 μm) and 60% ethanol was eluted with a flow rate of 0.8 mL / min and detected at UV 240 nm. The results of the analysis are shown in Fig. Peak of deoxyglycolipotoxin was observed at 9 minutes retention time in the total ethanol extract but deoxyglycolyticoxine was not observed in Diaion HP-20 resin solution. On the other hand, in the 100% ethanol eluate of Diaion HP-20 resin, a peak of deoxyglycolyticoxine was observed at a retention time of 9 minutes, and it was found that deoxyglycolyticoxine was purely separated by Diaion HP-20 resin. The high-performance liquid chromatography analysis was carried out by proton nuclear magnetic resonance spectroscopy ( 1 H-NMR) in order to identify the substance appearing at a retention time of 9 minutes, and the results are shown in FIG. The spectrum of this material is the same as that of the standard deoxyplateletoxin, indicating that the main component of the 100% ethanol eluate of Diaion HP-20 resin is deoxyglycolyticoxin.

Claims (4)

추출 대상물의 80% 알코올 추출액을 크로마토그래피 칼럼에 통과시켜 데옥시포도필로톡신을 칼럼에 흡착시키는 단계;
80% 알코올을 상기 칼럼에 통과시켜 흡착되지 않은 물질을 용출시키는 단계;
100% 알코올을 상기 칼럼에 통과시켜 흡착되어 있던 데옥시포도필로톡신을 용출시키는 단계;를 포함하는 데옥시포도필로톡신의 추출 방법.
Passing an 80% alcohol extract of the object to be extracted through a chromatography column to adsorb deoxyglycolipotoxin to the column;
Passing 80% alcohol through the column to elute the non-adsorbed material;
100% alcohol is passed through the column to elute deoxyglycolipotoxin that has been adsorbed.
제1항에 있어서, 상기 알코올은 메탄올 또는 에탄올인 데옥시포도필로톡신의 추출 방법.The method of claim 1, wherein the alcohol is methanol or ethanol. 제1항에 있어서, 상기 추출 대상물은 전호, 백두옹, 향나무, 측백나무, 나한백 및 토밀수로 이루어진 군에서 1종 이상 선택되는 것인 데옥시포도필로톡신의 추출 방법.2. The method according to claim 1, wherein the object to be extracted is at least one selected from the group consisting of Korean pepper, white radish, jade tree, Japanese white cabbage, Japanese white bean, and Korean soil. 제1항에 있어서, 상기 칼럼은 활성탄, Diaion HP-20 수지 및 Amberlite XAD-20 수지로 이루어진 군에서 선택되는 충전제로 충전된 것인 데옥시포도필로톡신의 추출 방법.The method of claim 1, wherein the column is filled with a filler selected from the group consisting of activated carbon, Diaion HP-20 resin and Amberlite XAD-20 resin.
KR1020180051133A 2017-05-12 2018-05-03 Process for Producing Deoxypodophilotoxin in Quantity KR102110966B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20170059379 2017-05-12
KR1020170059379 2017-05-12

Publications (2)

Publication Number Publication Date
KR20180124733A true KR20180124733A (en) 2018-11-21
KR102110966B1 KR102110966B1 (en) 2020-05-14

Family

ID=64602224

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180051133A KR102110966B1 (en) 2017-05-12 2018-05-03 Process for Producing Deoxypodophilotoxin in Quantity

Country Status (1)

Country Link
KR (1) KR102110966B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021230508A1 (en) * 2020-05-11 2021-11-18 주식회사 제이앤씨사이언스 Novel derivative of beta-apopicropodophyllin and preparation method therefor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040026272A (en) * 2002-09-23 2004-03-31 김종석 Cosmetic composition having whitening effect comprising extract of Pulsatilla Radix as main ingredient
KR20050023711A (en) * 2003-09-02 2005-03-10 에스케이케미칼주식회사 Effect of extracts from Pulsatilla koreana on the therapy of dementia
KR20110012431A (en) * 2009-07-30 2011-02-09 한국화학연구원 Method for preparing crude saponin composition enhanced purity and effective saponin contents from platycodon grandiflorum or the extract therefrom
KR20120055482A (en) * 2010-11-23 2012-05-31 대한민국(산림청 국립수목원장) Antibacterial composition containing anthriscus sylvestris extract

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040026272A (en) * 2002-09-23 2004-03-31 김종석 Cosmetic composition having whitening effect comprising extract of Pulsatilla Radix as main ingredient
KR20050023711A (en) * 2003-09-02 2005-03-10 에스케이케미칼주식회사 Effect of extracts from Pulsatilla koreana on the therapy of dementia
KR20110012431A (en) * 2009-07-30 2011-02-09 한국화학연구원 Method for preparing crude saponin composition enhanced purity and effective saponin contents from platycodon grandiflorum or the extract therefrom
KR20120055482A (en) * 2010-11-23 2012-05-31 대한민국(산림청 국립수목원장) Antibacterial composition containing anthriscus sylvestris extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021230508A1 (en) * 2020-05-11 2021-11-18 주식회사 제이앤씨사이언스 Novel derivative of beta-apopicropodophyllin and preparation method therefor

Also Published As

Publication number Publication date
KR102110966B1 (en) 2020-05-14

Similar Documents

Publication Publication Date Title
Alberti et al. Characterization of diarylheptanoids: an emerging class of bioactive natural products
EP2329816B1 (en) An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof
Wang et al. Cyclodepsipeptides from the ascocarps and insect-body portions of fungus Cordyceps cicadae
Heng et al. Analysis of the bioactive components of Sapindus saponins
Zhang et al. Antioxidant, anti‐inflammatory and cytotoxic activities of polyphenols extracted from Chroogomphus rutilus
TWI648257B (en) Compounds from antrodia camphorata, method for preparing the same and use thereof
CN110305092B (en) Guaiane sesquiterpenes and preparation and application thereof
KR20170049353A (en) Extraction method of high purity cordycepin
CN105503786B (en) Split Lignanoids compounds-smartweed diffractive ring lignan glucoside E and preparation method thereof
Turghun et al. UHPLC-MSn-assisted characterization of bioactive alkaloids extracted from Nitraria sibirica leaves and enriched using response surface method and adsorption on macroporous resin
ITRM20000293A1 (en) METHOD OF EXTRACTION OF PHARMACEUTICAL ACTIVITY PRODUCTS FROM SPERMAFITE PLANTS, PRODUCTS SO OBTAINED AND THEIR USE IN MEDICINE, IN PART
CN109694366B (en) Method for separating and purifying active ingredients of clematis filamentosa dunn
KR101080648B1 (en) A method for isolating and producing highly-concentrated Eupatilin and Jaceosidine from the extract of Artemisia species by using Centrifugal Partition Chromatography
CN105693806A (en) Medicine composition of almitrine dimesylate and medical application thereof
KR20180124733A (en) Process for Producing Deoxypodophilotoxin in Quantity
Akazawa et al. Three new cyclic diarylheptanoids and other phenolic compounds from the bark of Myrica rubra and their melanogenesis inhibitory and radical scavenging activities
CN111548327B (en) Carbon-reduced kaurane diterpene, preparation method thereof and application thereof in preparation of antitumor drugs
WO1993003039A1 (en) Carcinostatic compound and production thereof
CN113024498B (en) Ficus-japonica alkane sesterterpene compound, preparation method thereof, pharmaceutical composition and application thereof, and application of total extract of Ficus-japonica
CN111253352B (en) Compound extracted and separated from traditional Chinese medicine cymbidium maculatum, and preparation method and application thereof
CN109180632B (en) A method for preparing compound separated from radix Tripterygii Wilfordii
EP2999480B1 (en) Extract of hippeastrum papilio rich in galanthamine
CN111187323A (en) Hosta plantaginea flower extract and extraction method and application thereof
CN115974695B (en) Preparation method and application of vibsane diterpenoid compounds in coral tree
CN108948040A (en) The Germacrane Sesquiterpenoids compound extracted in a kind of Carpesium cernuum Linn and its application

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right